News

The acquisition positions Walgreens as one of the largest home infusion therapy providers in US and expands its respiratory therapy and durable medical equipment services. Option Care services

Mr Fogelman has more than 30 years of financial and accounting experience and has previously worked with International Aluminum Corporation. CytRx president and CEO Steven Kriegsman said: “Mitch

The court has ordered Ranbaxy to delay launching its product until expiration of the patent in July 2016. Ranbaxy may seek to appeal this decision. However, the court

This acquisition adds rolofylline, NovaCardia's investigational Phase III compound for acute heart failure, to Merck's pipeline. Merck has acquired all the outstanding equity of NovaCardia for a total

Philip Dean, CSO at De Novo, said: “We are very pleased to be working with Achaogen – a leader in the fight against drug-resistant bacteria.” Phillip Patten, senior

The randomized multinational study was conducted by Merck KGaA, and enrolled patients with stage IIIB or stage IV non-small cell lung cancer who had not previously received chemotherapy.

The Phase II trial is a single-blinded, placebo controlled, three-way crossover and randomized in up to 60 patients, with the endpoint of assessing the efficacy of TPM/Insulin in

Two of these trials will investigate the use of subcutaneous methylnaltrexone for treating opioid-induced constipation in patients outside of the palliative care population. The third trial will investigate

The Federal Trade Commission and the US Department of Justice, Antitrust Division have granted early termination of the Hart-Scott-Rodino waiting period for the previously announced merger agreement between